International
A medication, which is the first in a new class of drugs, can help reduce tics in kids with Tourette syndrome for up to 24 weeks, according to international research. The drug, called ecopipam, was able to reduce the incidence of tics in kids and was generally well-tolerated in the small trial. The result also pointed towards the drug reducing tics in adults, but small numbers of adults in the trial meant the result did not reach statistical significance. The main side effects were excessive sleepiness, headache, anxiety and insomnia. The authors say the results suggest that ecopipam could be a new drug treatment option for children, adolescents, and adults with Tourette syndrome.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
